Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-08-26), Evoq Remedies's 9-Day RSI is 36.25.
The industry rank for Evoq Remedies's 9-Day RSI or its related term are showing as below:
BOM:543500's 9-Day RSI is ranked better than 76% of 125
companies
in the Medical Distribution industry
Industry Median: 53.18
vs BOM:543500: 36.25
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Evoq Remedies 9-Day RSI Related Terms
BOM:543500 vs MCK, COR, CAH: 9-Day RSI Comparison
For the Medical Distribution subindustry, Evoq Remedies's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evoq Remedies 9-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Evoq Remedies's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Evoq Remedies's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evoq Remedies (BOM:543500) has a 9-Day RSI of 36.25 as of Aug. 26, 2026. According to the industry distribution chart, Evoq Remedies ranks #30 out of 125 companies in the Medical Distribution industry, placing it in the top 24%.
Is Evoq Remedies' 9-Day RSI too high?
Evoq Remedies' current 9-Day RSI is 36.25. The Medical Distribution industry median 9-Day RSI is 53.18. Evoq Remedies' value of 36.25 is 31.8% below this industry median. Based on the distribution chart, Evoq Remedies ranks #30 out of 125 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Evoq Remedies has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evoq Remedies' 9-Day RSI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Evoq Remedies ranks #30 out of 125 companies for 9-Day RSI. This places Evoq Remedies in the top 24% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 53.18. Evoq Remedies' value of 36.25 is 31.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Medical Distribution company?
The median 9-Day RSI among Medical Distribution companies is 53.18, based on 125 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evoq Remedies's current 9-Day RSI of 36.25 is 31.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median 9-Day RSI is 53.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evoq Remedies's current 9-Day RSI is 36.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evoq Remedies stock overvalued right now?
Based on GuruFocus' analysis, Evoq Remedies (BOM:543500) is currently considered Possible Value Trap. The stock's GF Value™ is ₹12.85, compared to a current price of ₹1.71 — trading 86.7% below its estimated fair value. The current 9-Day RSI is 36.25 and 31.8% below the Medical Distribution industry median of 53.18. Evoq Remedies' overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Evoq Remedies (BOM:543500), the current 9-Day RSI is 36.25 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evoq Remedies (BOM:543500) Overvalued in 2026?
Based on GuruFocus' analysis, Evoq Remedies stock appears to be undervalued.
The current stock price of ₹1.71 is trading 86.7% below its estimated GF Value™ of ₹12.85.
GuruFocus considers Evoq Remedies to be Possible Value Trap.
Key valuation signals for BOM:543500:
9-Day RSI: 36.25
GF Value™: ₹12.85 vs. price of ₹1.71 (86.7% below fair value)
Industry Position: 31.8% below the Medical Distribution median (#30 of 125)
No single metric tells the full story. See the BOM:543500 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading, and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections, and others. It operates in a single segment that is Pharmaceutical Trading.
58GF Score
Get the complete analysis for BOM:543500
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543500 has been successfully added to your 
